AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

FDA approves first transdermal gel for estrogen therapy.

Women's Health Weekly

| March 04, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 MAR 4 - (NewsRx.com & NewsRx.net) -- Solvay Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved EstroGel (estradiol gel), the first-ever estrogen therapy (ET) transdermal gel in the country for the treatment of moderate to severe vasomotor symptoms, as well as vulvar and vaginal atrophy associated with menopause.

EstroGel is a clear, odorless, hydro-alcoholic gel that provides for delivery of estradiol for estrogen replacement in a non-patch transdermal form.

"With the approval of EstroGel, women and healthcare professionals now have an additional hormone therapy option. EstroGel will offer healthcare providers the opportunity to individualize a woman's therapy to help manage vasomotor symptom relief," said Harold H. Shlevin, PhD, president and CEO of Solvay Pharmaceuticals, Inc.

EstroGel has been a prescribed therapy for more than 25 years in Europe. It will be available with a prescription in pharmacies throughout the United States by mid-2004.

Transdermal delivery of EstroGel ensures the body receives a consistent and ...

Related articles from newspapers, magazines, journals, and more
FDA approves EstroGel transdermal gel for estrogen therapy.
Magazine article from: Women's Health Weekly March 11, 2004 700+ words
...efficacy and tolerability of EstroGel in reducing the frequency...study analyzed the effects of EstroGel on 145 healthy, postmenopausal...severe hot flashes. "(EstroGel) represents a promising new...was prepared by Women's Health Weekly editors from staff and other...
EstroGel(R): First Ever Transdermal Gel for Estrogen Therapy Now Available in...
Press release article from: PR Newswire July 27, 2004 700+ words
...Pharmaceuticals, Inc. today announced that EstroGel(R) (estradiol gel), the first transdermal...Administration (FDA) on Feb. 9, 2004, EstroGel(R) is a clear, colorless, hydro...daily on one arm from wrist to shoulder, EstroGel(R) has a low incidence of application...
Solvay Pharmaceuticals, Inc. Receives U.S. FDA Approval for EstroGel; First...
Press release article from: Business Wire February 10, 2004 700+ words
...Drug Administration (FDA) has approved EstroGel(R) (estradiol gel), the first...atrophy associated with the menopause. EstroGel(R) is a clear, odorless, hydro...transdermal form. "With the approval of EstroGel(R), women and healthcare professionals...
EstroGel: first ever transdermal gel for estrogen therapy now available in the...
News wire article from: Asia Africa Intelligence Wire July 27, 2004 700+ words
...Solvay Pharmaceuticals Inc announced that EstroGel (estradiol gel), the first transdermal...and burning in and around the vagina. EstroGel is a clear, colourless, hydro-alcoholic...daily on one arm from wrist to shoulder, EstroGel has a low incidence of application site...
PDI Selected to Promote EstroGel(R) for Ascend Therapeutics.
Press release article from: PR Newswire January 31, 2006 700+ words
...their estrogen replacement therapy product, EstroGel, to the obstetrician/gynecologist market...re-acquired the rights to commercialize EstroGel, a product Ascend initially developed. EstroGel competes in the $1.3 billion estrogen...
FDA clears Solvay's EstroGel.(Brief Article)
Newspaper article from: Pharma Marketletter February 16, 2004 700+ words
...Administration has approved Belgium-based Solvay Pharmaceuticals' EstroGel (estradiol gel). The product is the first-ever estrogen...atrophy associated with the menopause, noted the company. EstroGel is a clear, odorless, hydro-alcoholic gel that has been...
EstroGel o.k.'d.(RXs)(Solvay Pharmaceuticals Inc)(Brief Article)
Magazine article from: Chain Drug Review March 15, 2004 700+ words
Solvay Pharmaceuticals Inc. has received FDA approval for EstroGel, the first transdermal gel for estrogen therapy in the United States. The product is for the treatment of moderate to severe vasomotor symptoms.
Charter Hospital Closings May Signal Bigger Problems Ahead, Reports Mental...
Press release article from: PR Newswire February 14, 2000 700+ words
...reports this week's issue of Mental Health Weekly. The stark numbers include 33 hospital...Karen Keiser-Jenkins told Mental Health Weekly last week. Keiser-Jenkins says the...Newswire. For more information on Mental Health Weekly, click on "Newsletters" to receive...
Problems With Managed Mental Health Program Hold Lesson For Other States,...
Press release article from: PR Newswire February 15, 1999 700+ words
...contract in state history, this week's issue of Mental Health Weekly reports. Earlier this month, the Montana legislature...Magellan. Center executive director Paul Meyer told Mental Health Weekly that in the last six months, Magellan has denied $500...
News You Can Use.(Rachel's Environmental and Health Weekly, periodical)(Brief...
Magazine article from: E Franz, Damon January 1, 2000 700+ words
...weekly publication of the Environmental Research Foundation (ERF). Much like its namesake, Rachel's Environment and Health Weekly sounds the warning about hazardous substances and technologies that threaten human and that environmental health. Rachel...
For more facts and information, see all results

Source: HighBeam Research, FDA approves first transdermal gel for estrogen therapy.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA